Storage and handling
Store at 20° to 25° C (68° to 77° F)
Store at 20° to 25° C (68° to 77° F)
Store at 20° to 25° C (68° to 77° F)
| Class | Version | Type | Effective |
|---|---|---|---|
| BROMFENAC Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20191108 |
| PREDNISOLONE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Data code | Code 39 | LG21121 | pgb3.jpg |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 70261-504-03 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-c1c3-f424-e053-dadaa90a57ce | 65d1a00a-54fb-5afd-e053-2991aa0a69a9 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70261-504-03 | Pred-Gati-Brom | 3.5 mL in 1 BOTTLE, DROPPER | SUSPENSION/ DROPS | 3.5 | 1 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70261-504-03 | ML - Milliliter | 70261-504 | 8af2509a-9979-423c-97e0-bb1ce15d0976 | 1 | 2021-06-02 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 70261-504 | 70261-504-03 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| GATIFLOXACIN HEMIHYDRATE | AN201CY09J | ACTIB |
| BROMFENAC | 864P0921DW | ACTIB |
| PREDNISOLONE ACETATE | 8B2807733D | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 65d1a00a-54fc-5afd-e053-2991aa0a69a9 | 65d1a00a-54fb-5afd-e053-2991aa0a69a9 | 2018-02-22 | 65d1a00a-54fc-5afd-e053-2991aa0a69a9 65d1a00a-54fb-5afd-e053-2991aa0a69a9 |
Adverse event summaries are temporarily unavailable. Other product information remains available.